Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Mr3Putt's Profile
Displaying 51-100 of 221 result(s).
CYDY CytoDyn Inc
07/28/2025 6:40:22 PM
updates posted to CRC trial: https: (7)
CYDY CytoDyn Inc
07/28/2025 9:48:14 AM
Your question is answered precisely (2)
CYDY CytoDyn Inc
07/27/2025 3:21:58 PM
Upwithstock to the rescue: https:// (13)
CYDY CytoDyn Inc
07/25/2025 2:27:56 PM
“Big news! Several years in the m (4)
CYDY CytoDyn Inc
07/23/2025 6:35:43 PM
Thoughts? Upwithstock IIRC has addr (5)
CYDY CytoDyn Inc
07/22/2025 7:05:07 PM
UWS responds to you at r/Livimmune: (3)
CYDY CytoDyn Inc
07/22/2025 10:44:56 AM
The Jun 24 PR stated that the compa (8)
CYDY CytoDyn Inc
07/21/2025 10:31:35 PM
Require reading for the frustrated (14)
CYDY CytoDyn Inc
07/21/2025 7:01:29 AM
This info got posted at reddit/Livi (7)
CYDY CytoDyn Inc
07/18/2025 3:16:45 PM
Yeah we're at Lord of the Flies lev (9)
CYDY CytoDyn Inc
07/17/2025 4:39:47 PM
Yes and no. :( (1)
CYDY CytoDyn Inc
07/15/2025 2:54:19 PM
Imagine news I try man, I try. Gett (9)
CYDY CytoDyn Inc
07/13/2025 9:58:07 AM
This P1 is a very public study unde (6)
CYDY CytoDyn Inc
07/09/2025 7:51:47 AM
“You’ve got to ask yourself one (5)
CYDY CytoDyn Inc
07/07/2025 6:21:49 PM
FWIW on July 9 it'll be the one yea (5)
CYDY CytoDyn Inc
07/07/2025 10:31:49 AM
Not a pharma rep nor exec so I have
CYDY CytoDyn Inc
07/07/2025 10:05:14 AM
Paying Cytodyn dosen't get them ICI
CYDY CytoDyn Inc
07/07/2025 9:46:29 AM
If LL makes all ICI's better, why w (4)
CYDY CytoDyn Inc
07/07/2025 7:22:13 AM
IIRC by July 2nd of this month.
CYDY CytoDyn Inc
07/06/2025 3:29:39 PM
what do you believe.?? I'm a Navy m (4)
CYDY CytoDyn Inc
07/04/2025 6:59:01 AM
for the short attention span reader (11)
CYDY CytoDyn Inc
07/02/2025 10:38:36 AM
IIRC, It's the Cornell trial, if it (2)
CYDY CytoDyn Inc
07/01/2025 2:52:16 PM
4 July 1500-ish central euro time. (3)
CYDY CytoDyn Inc
06/26/2025 7:08:21 AM
They are doing a review early on an (13)
CYDY CytoDyn Inc
06/25/2025 6:11:41 PM
Suboptimal dosing and we're always (14)
CYDY CytoDyn Inc
06/25/2025 6:03:00 PM
Abstract is up: 134eP - Observed su (11)
CYDY CytoDyn Inc
06/24/2025 8:31:28 AM
Dosed first patient. No other news (3)
CYDY CytoDyn Inc
06/23/2025 8:12:18 PM
They’d have to PR that kind of ne
CYDY CytoDyn Inc
06/23/2025 9:07:28 AM
Count me among the folks who were n (3)
CYDY CytoDyn Inc
06/23/2025 6:55:37 AM
(4)
CYDY CytoDyn Inc
06/21/2025 10:19:50 AM
I'm reaching for a Brawndo right no (1)
CYDY CytoDyn Inc
06/20/2025 7:50:53 AM
Rumsfeld theorem applies: There are (5)
CYDY CytoDyn Inc
06/19/2025 7:27:31 AM
Can we assume that there was some s (1)
CYDY CytoDyn Inc
06/09/2025 7:14:25 AM
Like maybe a patient story here: ht (4)
CYDY CytoDyn Inc
06/08/2025 1:56:52 PM
Gonna go with a not started based o
CYDY CytoDyn Inc
06/07/2025 6:31:42 PM
at HP we used to say if we were mar (3)
CYDY CytoDyn Inc
06/07/2025 8:23:57 AM
I don't recall seeing the data PR'd (6)
CYDY CytoDyn Inc
06/06/2025 9:10:24 PM
134eP - Observed Survival Following (11)
CYDY CytoDyn Inc
06/04/2025 12:40:14 PM
What I don't see in your post and w (7)
CYDY CytoDyn Inc
06/03/2025 11:57:46 AM
I was looking into how CYDY could m (2)
CYDY CytoDyn Inc
05/30/2025 10:02:21 AM
How 'bout a Fresca!
CYDY CytoDyn Inc
05/30/2025 6:59:12 AM
someone here previously mentioned t (6)
CYDY CytoDyn Inc
05/21/2025 6:48:12 PM
Minor website update New CFO Hoffma (1)
CYDY CytoDyn Inc
05/21/2025 4:38:09 PM
Mr. Chowder is pretty much spot on: (2)
CYDY CytoDyn Inc
05/20/2025 8:29:06 AM
but the deal structure? That would (2)
CYDY CytoDyn Inc
05/20/2025 8:20:56 AM
would we take a licensing deal like (6)
CYDY CytoDyn Inc
05/18/2025 6:43:46 PM
got $3000? https://www.ihealthcarea (1)
CYDY CytoDyn Inc
05/17/2025 10:24:54 AM
Here's link to the Da (8)
CYDY CytoDyn Inc
05/17/2025 8:28:33 AM
Here's a couple more breadcrumbs: D (11)
CYDY CytoDyn Inc
05/16/2025 9:40:34 AM
Definitely check out this post at r (11)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Discover Cutting-Edge Motion Control for Life Sciences
  • NexPoint Residential Trust Declares Increased Quarterly Dividend
  • Investigation of Quantum Corporation’s Stock Actions and Risks
  • ADP Revolutionizes Employment Reporting with Weekly Data Insights
  • NexPoint Residential Trust Delivers Strong Q3 2025 Performance
  • Exploring the Current Pricing Stability of Dogecoin
  • Discover the Versatile HopLite Stroller for Modern Families
  • AMD Teams Up with US Department of Energy for Major AI Project
  • Reusables.com Introduces Game-Changing Reusable Packaging System
  • PayPal and OpenAI Transform E-Commerce with New Deal
  • Transforming CRE: Altrio's Deal Execution Platform Success
  • AI Revolution in Real Estate: Challenges and Successes Ahead
  • Enhancing Resident Retention Through Technology and Service
  • Grand Bay Hotel Welcomes Marriott Partnership for Future Growth
  • NexPoint Residential Trust, Inc. Boosts Dividend by 3.9%
  • LEEF Brands Announces Q3 2025 Financial Results and Call
  • NexPoint Residential Trust Announces 2025 Q3 Financial Performance
  • Soleno Therapeutics Announces November Conference Participation
  • Jim Cramer Urges Investors: Time to Sell Super Micro Computer
  • Pan American Energy Advances Exploration at Tharsis Project
  • Rambus Inc. Faces Earnings Setback Amid Market Movement
  • Nuvini Group Welcomes Roberto Otero as New CFO to Enhance Strategy
  • Exploring Sea Limited's Path After $40 Million Settlement
  • BrainsWay's Upcoming Financial Results: Major Updates Ahead
  • Wendy's Quality Decline: A Look at the Challenges Ahead
  • Reviva Pharmaceuticals to Showcase Schizophrenia Treatment Data
  • Great Lakes Dredge & Dock Corporation to Release Q3 2025 Results
  • Independent Bank Corp's Strong Q3 Results and Outlook
  • Rigetti Computing's Upcoming Financial Report Highlights
  • Luma's Inspiring Journey: Transforming Healthcare Accessibility
  • CTS Corporation Reports Strong Financial Growth and Future Outlook
  • Innovative IBSRELA Data Show Positive Impact at Gastro Meeting
  • Empowering Businesses with GBG's Innovative Digital ID Solutions
  • Bread Financial Ventures into Private Notes Offering of $500M
  • Franklin Electric Reports Impressive Q3 2025 Financial Growth
  • Empowering Students: Grange Insurance's Innovative Internship Program
  • Sysco's Q1 2026 Highlights: Growth in Earnings and Sales
  • Clay Heskett's Reelection Marks New Era for L.E.K. Consulting
  • Uni-Fuels H1 2025 Financial Highlights and Strategic Expansion
  • DataStrike's Dramatic Growth and the Shift to Onshore Support
  • NAPC Defense Gains Momentum in Global Tactical Systems Market
  • Skyline Bankshares Reports Impressive Q3 Earnings Growth
  • Winthrop Wealth Welcomes Mercer Asset Management Partner
  • Inseego Launches Innovative FX4200 Router for Enterprise 5G Access
  • Integral Molecular's Membrane Array Approaching FDA Status
  • Nautilus Biotechnology: Q3 Financial Review and Future Outlook
  • Clearmind Medicine's CEO Highlights Women's Role in Psychedelics
  • Revolutionary Blood Test by Mercy BioAnalytics for Ovarian Cancer
  • TeraWulf Releases Promising Financial Outlook for Q3 2025
  • QuickLogic Sets Conference Call for Q3 Fiscal Insights
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site